Connect your AI

AARD AARD Investment Purchases

Investment Purchases at other companies

Relmada Therapeutics, Inc.RLMD

$149.52M+30,544%

Rhythm Pharmaceuticals, Inc.RYTM

$42.2M+25.9%

Viking TherapeuticsVKTX

$72.44M-68.9%

Protagonist TherapeuticsPTGX

$68.97M-67.8%

Other financials

Income statement

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

Return on equity-58.8%—

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AARD's investment purchases?: AARD (AARD) reported investment purchases of $0 in Q1 2026.
How has AARD's investment purchases changed year-over-year?: AARD's investment purchases decreased by 100.0% year-over-year, from $124.65M to $0.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.